› Forums › General Melanoma Community › ASCO cont – responses to anti-PD-1 including retreatment
- This topic has 3 replies, 3 voices, and was last updated 6 years, 7 months ago by
Bubbles.
- Post
-
- June 27, 2019 at 4:56 pm
Links attached that show results to anti-PD-1 therapy in melanoma patients as reported at ASCO 2017 and 2018 with a report from this year that takes a retrospective look at folks who initially responded to anti-PD-1 and were retreated upon progression later. If you’re interested: https://chaoticallypreciselifeloveandmelanoma.blogspot.com/2019/06/anti-pd-1-results-in-melanoma-patients.html
les
Viewing 1 reply thread
- Replies
-
-
- June 28, 2019 at 2:08 pm
Hi Celeste, I agree with your feelings about the retrospective design including one treatment folks!!! The data does make one think that if a pd-1 patients needs future treatment due to progression after stopping treatment, that clinical trials or Ipi+nivo combination might be better choice than using pd-1 monotherapy a second time!!!!Best Wishes!!!Ed
Viewing 1 reply thread
- You must be logged in to reply to this topic.